- This narrative review synthesizes evidence on preoperative anemia, RBC transfusion, and postoperative outcomes in cardiac surgery patients.
- It emphasizes causal inference mediation analysis to separate the direct effects of anemia from transfusion-mediated effects.
- The authors suggest transfusion mediates a substantial share of anemia-associated mortality, while direct anemia effects seem more important for renal complications.
- They argue for individualized transfusion strategies over uniform thresholds, weighing the benefits of correcting anemia against transfusion risks for each outcome.
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
- It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
- Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
- Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
- This educational review traces the history of pediatric congenital cardiac anesthesia, from the first patent ductus arteriosus ligation in 1938 to current practice.
- It covers advances in surgery, bypass technology, myocardial protection, monitoring, intensive care, and anesthetic management that enabled survival into adulthood for most children with CHD.
- The specialty's focus has shifted from reducing perioperative mortality to improving lifelong outcomes as the adult CHD population has grown.
- The authors conclude that multidisciplinary collaboration and continued scientific progress are central to improving safety, recovery, and long-term outcomes.
- This scoping review of 21 studies, selected from PubMed and Embase searches, examined adults undergoing cardiac surgery with cardiopulmonary bypass.
- Predictors were grouped as patient-related, procedure-related, or postoperative, and as independent or non-independent.
- Intubation duration, transesophageal echocardiography use, reoperation, and multi-valve procedures were consistently associated with swallowing dysfunction.
- Instrumental assessments identified more granular independent predictors, while bedside screening identified factors tied to functional status and perioperative management.
- This scoping review (PRISMA-ScR, searches of MEDLINE, Embase, and Scopus through July 2025) included 16 studies of parenteral vasopressors in adults undergoing major surgery, totaling 6,927 patients.
- Most included studies were small, single-center, observational designs, mainly in cardiothoracic surgery, and compared a range of vasopressor regimens, with no two studies comparing identical regimens.
- Initiation criteria varied widely, split between hypotension-based triggers and vasoplegic syndrome, which was inconsistently defined; eight studies reported significant differences in postoperative outcomes between strategies.
- The authors found no vasopressor strategy with consistent benefit across studies and concluded the evidence is fragmented, calling for standardized definitions and adequately powered multicenter trials.
- This narrative review synthesizes literature on perioperative management of G6PD deficiency in patients undergoing cardiac surgery, noting a global prevalence of about 450 million individuals.
- It covers avoiding oxidative stress and triggering medications, and notes that propofol, dexmedetomidine, and remifentanil may have antioxidant properties.
- Centrifugal pumps and minimized CPB circuitry are described as producing less inflammation than roller pumps or conventional circuits, and normothermia may help prevent hemolysis.
- The authors conclude that strategies to mitigate intraoperative hemolysis are needed and that clinicians should watch closely for signs of hemolysis.
- This review article covers sotatercept, a recombinant fusion protein for pulmonary arterial hypertension, across preclinical work, major trials, and heart failure applications.
- Sotatercept is described as a fusion of the activin receptor 2A extracellular domain with an IgG1 Fc fragment that traps activins and growth differentiation factors.
- The review examines clinical trial findings on hemodynamics, symptoms, exercise, quality of life, and mortality, but the abstract reports no effect sizes.
- The authors conclude that sotatercept gives temporally durable benefits and a striking reversal of disease consequences, and they flag adverse effects and anesthetic implications.
- This scoping review of MEDLINE, Scopus and Embase searches identified 15 observational studies comparing post-operative complications in Aboriginal and Torres Strait Islander and non-Indigenous Australian adults after cardiac surgery.
- Most included studies examined isolated CABG (seven) or a mix of CABG and valve surgery, with only two focused on isolated valve surgery.
- Studies reported higher rates of myocardial infarction, kidney failure and long-term mortality in Aboriginal and Torres Strait Islander patients, with CABG differences largely attributed to greater preoperative comorbidity.
- No interventional studies were identified, and several relevant variables such as socioeconomic status, frailty and malnutrition were not evaluated, so the authors call for further research.
- This narrative review summarizes critical care management of acute fulminant myocarditis, a life-threatening syndrome causing rapidly progressive cardiogenic shock.
- It covers early diagnosis with endomyocardial biopsy and cardiac MRI, tailored vasopressor and inotrope use, and early escalation to temporary mechanical support, most commonly VA-ECMO, for refractory shock.
- It also addresses arrhythmia risk, multiorgan management, and phenotype-driven immunomodulatory treatment strategies.
- Systematic review and meta-analysis of 11 randomized controlled trials covering 2,473 adults recovering from cardiac surgery.
- Compared high-flow nasal cannula (HFNC) with conventional oxygen therapy, with the main outcome being need for escalation of respiratory support.
- HFNC reduced escalation of respiratory support (RR 0.71; 95% CI 0.55-0.93; p = 0.01) and increased delirium (RR 3.63; 95% CI 1.80-7.30; p = 0.0003).
- The authors found better oxygenation with HFNC, but no difference in mortality, reintubation, or hospital length of stay.
- Systematic review and meta-analysis of 17 RCTs (N=2288) comparing NIRS-guided with usual-care intraoperative management in adults undergoing on-pump cardiac surgery.
- Outcomes assessed included postoperative cognitive decline, delirium, stroke, mortality and functional recovery.
- NIRS guidance probably reduced early postoperative cognitive decline (RR 0.65, 95% CI 0.42-0.99; moderate certainty).
- Effects on stroke, mortality and delirium were imprecise with low certainty, and no included trial measured validated quality of life or function.
- This narrative review covers anesthetic management of open and endovascular thoracoabdominal aortic aneurysm repair; the abstract reports no primary patient data.
- The authors propose a stepwise algorithm that uses transesophageal echocardiography as a real-time decision aid, beginning with standardized baseline imaging.
- TEE may help separate preload depletion from contractile dysfunction, assess afterload and vasoplegia, and guide fluids, vasoactive drugs, bypass flow, and inotropes.
- In endovascular repair, TEE may aid landing-zone optimization, confirm true-lumen wire position, and help detect endoleaks or suspect retrograde dissection.
AI summary not available. Read the source abstract on PubMed.
- This scoping review of 135 studies on IVIG in cardiac surgery, heart transplantation, or infective endocarditis included case reports as well as 7 RCTs and 1 RCT protocol.
- Studies were mostly in heart transplantation, followed by nontransplant cardiac surgery and infective endocarditis, with standard IVIG at 2 g/kg the most common formulation and dose.
- The abstract reports no pooled effect sizes, confidence intervals, or p values; RCT outcome data were abstracted but not summarized numerically.
- The authors conclude the available evidence does not justify routine IVIG use in cardiac surgery and call for larger, prospectively registered, high-quality RCTs.
- This narrative review synthesizes 2025 AHA and ASE guidance and recent evidence on intraoperative TEE in adult cardiac surgery.
- It proposes a phase-based framework that links established TEE findings for preload, afterload, and contractility to specific management decisions.
- No pooled or quantitative results are reported, and emerging measures such as left atrial strain and 3D RV ejection fraction have limited intraoperative validation.
- The authors note that many thresholds come from transthoracic or ICU populations and that the framework is conceptual and needs prospective validation.
- This is a narrative review of cerebral arterial gas embolism across cardiac, aortic, mechanical circulatory support, and catheter-based procedures.
- It covers procedure-specific mechanisms, presentation from intraoperative collapse to delayed focal deficits, diagnosis, acute management, and prevention.
- The authors note CAGE is fundamentally a clinical diagnosis because intracranial air appears on CT in only a minority of confirmed cases, and hyperbaric oxygen is the definitive treatment.
- Most mechanisms are preventable with circuit vigilance, standardized deairing, and human factor safeguards, though cavitation and outgassing may occur despite optimal technique.
- The paper reviews anticoagulation approaches for patients with traumatic brain injury who are supported on ECMO for ARDS-related hypoxemic respiratory failure.
- The abstract draws on case reports and retrospective studies that it describes as showing efficacy for various anticoagulation strategies.
- It cites emerging literature suggesting ECMO may reduce mortality in TBI patients with concurrent ARDS, but gives no specific figures.
- The authors aim to outline these approaches and report their complications and outcomes, which the abstract does not quantify.
- This is an expert consensus decision pathway and review, not a primary study, so it reports no enrolled patients or new outcome data.
- It updates the 2023 pathway with probability-based diagnosis, the HFpEF-ABA screening score, and a cardiovascular-kidney-metabolic framing.
- SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists are positioned as foundational therapy, with finerenone favored over steroidal agents; ARNI is selectively considered.
- The authors note that several pivotal trials enrolled patients with ejection fractions starting at 40% or 45%, and benefits were often driven by fewer worsening heart failure events rather than cardiovascular mortality.
- Systematic review and meta-analysis of RCTs in adults undergoing cardiac surgery with cardiopulmonary bypass; 105 trials identified, 39 pooled.
- Compared ventilation strategies across the preoperative, intraoperative and postoperative periods, with all-cause mortality as the primary outcome.
- Ventilation during bypass reduced postoperative pulmonary complications (RR 0.87, 95% CI 0.79 to 0.96; P=0.005; 15 studies).
- Postoperative noninvasive respiratory support showed a non-significant mortality trend (RR 0.60, 95% CI 0.34 to 1.08; five studies).
AI summary not available. Read the source abstract on PubMed.
- This PRISMA 2020 systematic review of 6 included studies, drawn from 1,155 retrieved records, examined racial and socioeconomic differences in new-onset POAF after isolated CABG.
- The authors searched Cochrane, MEDLINE, and Embase and assessed risk of bias with the JBI Critical Appraisal Tool.
- White patients had a higher reported incidence of POAF than African American and other groups, but African American patients appear to have worse survival after developing POAF.
- Income, education, insurance status, and other access-to-care variables were inconsistently reported or adjusted for, so the authors call for further work on these factors.
- Systematic review and meta-analysis of 6 studies (2 RCTs, 4 cohort studies; n = 834) in adults undergoing cardiac surgery with cardiopulmonary bypass, all from East Asia.
- Compared perioperative sivelestat sodium, a neutrophil elastase inhibitor, with standard care for preventing postoperative lung injury and ARDS.
- ARDS incidence favored sivelestat but was not significant (Peto OR 0.19, 95% CI 0.03-1.16; I² 91.3%), and mortality was also nonsignificant (OR 0.69, 95% CI 0.35-1.39).
- The authors describe a consistent directional benefit limited by heterogeneity, rate the certainty of evidence as very low, and call for larger multicenter RCTs.
- Systematic review of 14 retrospective studies on nonfibrinogen factor concentrates in LVAD patients, drawn from 2,355 records screened through June 2026.
- For bleeding at implant or exchange, 134 patients received PCC and 487 received usual management or frozen plasma.
- The authors judged PCC likely safe and effective when used first-line and protocolized, while higher-dose rFVIIa was associated with thrombosis and mortality.
- For emergency anticoagulation reversal, PCC was linked to faster INR normalization without excess harm, but the safety of low-dose rFVIIa or FEIBA could not be judged.
- This is a narrative review, the first of two articles, on the cardiovascular pharmacology of GLP-1 receptor agonists.
- It covers GLP-1 physiology, drug development, and major clinical trials and substudies of GLP-1 receptor agonists in patients with or at high risk for atherosclerotic disease and type 2 diabetes.
- The review reports that GLP-1 receptor agonists reduce major adverse cardiovascular events in these patients, and that semaglutide protects in obesity with established cardiovascular disease but not in type 2 diabetes.
- The authors note that unanticipated cardiovascular and renal benefits led to use beyond diabetes and obesity, including in chronic kidney disease and heart failure with preserved ejection fraction.
- This is a perspective article rather than an original study, so it reports no new data, sample, or numerical results.
- It argues that perioperative bleeding in cardiac surgery remains hard to predict and that existing risk scores and newer analytics have not yet reached bedside decision support.
- The authors contend the central question is no longer whether bleeding can be predicted, but whether prediction actually improves care and outcomes.
- They call for clinically relevant outcomes, time-varying models, rigorous external validation, interpretability suited to use, and seamless workflow integration.
- This narrative review synthesizes HIT in cardiac surgery, covering epidemiology, pathophysiology, disease phases, diagnosis, and CPB-specific considerations.
- It covers bivalirudin and its limitations in renal dysfunction, plus heparin-enabling options such as plasma exchange, IVIG, protamine infusion, and antiplatelet agents.
- The authors propose an algorithm that weighs antibody status, functional assay results, surgical urgency, and patient-specific factors to guide anticoagulation choice.
- The stated aim is to help multidisciplinary teams select anticoagulation for acute, subacute, or remote HIT undergoing cardiac surgery.
- This bibliometric analysis examined 725 enhanced recovery after cardiac surgery publications indexed in Web of Science from 1979 to 2026.
- The study used no intervention or comparator; it mapped research themes through co-occurrence, clustering, and temporal keyword analyses.
- Annual output rose markedly after 2015, with the United States and Canada leading in productivity and influence, and major themes included multimodal analgesia and perioperative management.
- The authors describe a shift from early extubation toward integrated perioperative care pathways and note that high-quality randomized evidence remains limited.
- This is a descriptive paper proposing a bedside weaning strategy for microaxial flow pumps (Impella), and the abstract reports no study population or outcome data.
- The proposed "E.R.I.L." protocol has four pillars: echocardiography, reconditioning with inotropes and Impella support, stepwise reduction guided by hemodynamics, and lung ultrasound with VExUS when appropriate.
- The stated aim is to identify the optimal timing to stop the pump, both when used alone and with V-A ECMO (ECPELLA), while limiting device complications and preserving enough support for left ventricular recovery.
- This scoping review (PRISMA-ScR) mapped 57 primary studies and 15 reviews on 4-factor PCC in adults undergoing on-pump cardiac surgery.
- The comparator was FFP, and reported PCC dosing ranged from fixed 500-4000 IU to weight-based 15-30 IU/kg.
- Evidence consistently suggests PCC reduces chest tube output and transfusion versus FFP, though effect sizes vary; no pooled estimates are reported.
- The authors conclude that gaps remain on optimal dose, timing, viscoelastic targets, and fibrinogen sequencing, with limited cost-effectiveness data and rare serious adverse events.
- This expert review by a 12-clinician panel from 6 institutions drew on a PubMed and Embase literature search to build a vasoplegic shock management framework.
- The panel's algorithm recommends norepinephrine first-line, early vasopressin, then angiotensin II for escalation, with methylene blue, hydroxocobalamin, or corticosteroids considered in refractory cases.
- Reported risk factors include preoperative renin-angiotensin-aldosterone inhibition, prior cardiac surgery, longer bypass duration, and higher transfusion burden, with incidence cited as 5% to 50%.
- The authors conclude that vasoplegic shock is common and carries high mortality, and they offer the pathway as practical guidance while noting future research priorities.
- This narrative review synthesizes mainly observational studies and small registries on VA-ECMO support during high-risk ventricular tachycardia ablation.
- It compares VA-ECMO with less invasive options such as intra-aortic balloon pump or microaxial support, and preemptive versus rescue support strategies.
- VA-ECMO appears to improve procedural feasibility by preserving perfusion, but the authors do not support routine use over less invasive modalities.
- Current evidence shows favorable acute arrhythmia control without a clear survival benefit, so VA-ECMO is best reserved for carefully selected patients.
- This narrative review covers the pathophysiology, risk factors, prediction, and treatment of vasoplegia after cardiac surgery with cardiopulmonary bypass.
- Vasoplegia is described as low systemic vascular resistance with maintained or elevated cardiac index that resists fluids or vasopressors, though no formal definition exists.
- Listed risk factors span preoperative demographics, comorbidities, and medications, plus intraoperative factors such as bypass use, transfusion, and poor temperature control.
- Postoperative vasoplegia is linked to higher morbidity and mortality, and the review covers multimodal vasopressor regimens and biomarkers or dynamic monitoring under study for prediction.
- This review summarizes contemporary evidence on percutaneous closure of complex patent foramen ovale anatomy, including long tunnels, large defects, and atrial septal aneurysms.
- It describes how TEE, ICE, and 3-dimensional imaging are used to detect and characterize these anatomic variants.
- It highlights procedural approaches such as tunnel angioplasty, transseptal puncture technique, and device selection.
- The authors describe procedural success as acceptable and long-term outcomes as favorable, but the abstract reports no quantitative results.
- This is a narrative review of perioperative care for patients with resectable non-small cell lung cancer treated with immune checkpoint inhibitors, with no pooled sample or quantitative analysis.
- It compares immunochemotherapy with chemotherapy alone, and notes that myocarditis and pneumonitis are the most fatal perioperative immune-related adverse events, sometimes requiring surgical delay of up to 6 weeks.
- Most recent trials report no increased surgical complexity after immunochemotherapy, though the authors caution that cycle number, surgical timing, and surgeon-difficulty grading are not standardized.
- The authors urge anesthesiologists to screen for immune-related adverse events and surgical complexity predictors within a multidisciplinary team, and flag opioid effects and prehabilitation as areas needing research.
- This comprehensive review covers perioperative anesthetic management of patients with durable or temporary left ventricular assist devices undergoing non-cardiac surgery.
- It addresses preoperative device interrogation, right ventricular assessment, volume optimization, and anticoagulation planning, plus intraoperative monitoring of arterial pressure, TEE when feasible, preload, afterload, and pump flow.
- Key goals highlighted are maintaining mean arterial pressure, preventing right-heart failure, avoiding suction events, and routinely checking device function.
- The authors conclude that non-cardiac surgery can be performed safely at specialized centers with standardized protocols, advanced monitoring, and structured team education, with postoperative care in an intensive care setting familiar with mechanical circulatory support.
- This narrative review summarizes anatomy, mechanism, and physiology of stellate ganglion block (SGB) in refractory ventricular tachycardia and electrical storm, and reviews the supporting literature.
- The review covers SGB as an add-on to standard antiarrhythmic, ablation, and circulatory support strategies for refractory ventricular arrhythmias.
- Observational studies, case series, retrospective studies, and meta-analyses report that SGB can reduce arrhythmia episodes, but the abstract gives no effect sizes.
- The authors judge the evidence weak because no randomized controlled trials exist, and they suggest SGB may serve as bridge therapy until long-term management.
- This narrative review covers perioperative care of end-stage renal disease patients on renal replacement therapy undergoing major cardiac surgery.
- It describes preoperative steps such as dialysis timing, electrolyte correction, hemoglobin optimization, and bleeding-risk assessment, plus intraoperative goal-directed fluids and hemofiltration on the bypass circuit.
- The abstract reports no pooled data or quantitative outcomes; it recommends early postoperative renal replacement therapy, with continuous modalities favored in unstable patients.
- The authors stress a multidisciplinary, individualized approach involving cardiologists, nephrologists, anesthesiologists, and cardiac surgeons to reduce complications.
- This narrative review searched PubMed, Embase, and the Cochrane Library through September 2025 and organized regional anesthesia options for TAVI by access route.
- For transfemoral TAVI, the review treats local infiltration with monitored anesthesia care as the default, noting that regional anesthesia has not been shown to improve major clinical outcomes.
- Selective adjuncts such as ilioinguinal-iliohypogastric and fascia iliaca blocks may reduce sedative or opioid needs, while for non-transfemoral access regional techniques may preserve ventilation and stabilize hemodynamics.
- The authors conclude that regional anesthesia should be used selectively and that direct comparisons with local infiltration plus monitored anesthesia care are still needed.
- This is a critical narrative review of clinical controversies, not a primary study, and it reports no pooled sample size or quantitative results.
- It explains mechanical power as a single energy-per-unit-time measure that combines tidal volume, pressure, and flow, in contrast to static parameters such as tidal volume and PEEP.
- The authors conclude that current evidence is insufficient to show that mechanical power is independently associated with postoperative pulmonary complications.
- They suggest it may be a reasonable supplement to static parameters in high-risk patients, with excess power curbed by adjusting flow and respiratory rate, and call for standardized studies.